Morepen Laboratories Limited (NSE:MOREPENLAB)
India · Delayed Price · Currency is INR 42.69
-0.38 (-0.88%)
Apr 23, 2026, 3:29 PM IST
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 23.56 billion as of April 23, 2026. Its market cap has decreased by -10.16% in one year.
Market Cap
23.56B
Enterprise Value
24.34B
Revenue
17.87B
Ranking
n/a
PE Ratio
23.69
Stock Price
42.69
Market Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 23.56B, an increase of 172.08%. That is a compound annual growth rate of 3.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 23.56B | 4.67% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 48.03B |
| Innova Captab | 42.48B |
| RPG Life Sciences | 33.48B |
| Orchid Pharma | 28.88B |
| Solara Active Pharma Sciences | 23.68B |
| Indoco Remedies | 19.90B |
| Windlas Biotech | 18.27B |
| Beta Drugs | 13.89B |